TARA MOORE: Open Payments
NPI 1417414293 · NASHUA, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 66 payments from 12 companies in 2025. Trend: 2023 $1,234 · 2024 $1,362 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $382 |
| PFIZER INC. | 10 | $270 |
| E.R. Squibb & Sons, L.L.C. | 20 | $268 |
| Edwards Lifesciences Corporation | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Alnylam Pharmaceuticals Inc. | 4 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $80 |
| Amgen Inc. | 4 | $73 |
| Philips North America LLC | 1 | $41 |
| Baxter Healthcare | 1 | $37 |
Products named: ELIQUIS, CAMZYOS, WAINUA, FARXIGA, SAPIEN 3 Ultra RESILIA, LEQVIO, AMVUTTRA, JARDIANCE.
Industry payments across NH — which companies pay providers there.
